Free Trial

Cardinal Health Q3 2023 Earnings Report

Cardinal Health logo
$126.40 -0.61 (-0.48%)
As of 03/7/2025 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Cardinal Health EPS Results

Actual EPS
$1.74
Consensus EPS
$1.48
Beat/Miss
Beat by +$0.26
One Year Ago EPS
$1.45

Cardinal Health Revenue Results

Actual Revenue
$50.50 billion
Expected Revenue
$49.63 billion
Beat/Miss
Beat by +$869.82 million
YoY Revenue Growth
+12.60%

Cardinal Health Announcement Details

Quarter
Q3 2023
Time
Before Market Opens

Conference Call Resources

Conference Call Audio

Slide Deck

Remove Ads

Cardinal Health Earnings Headlines

Cardinal Health Target of Unusually Large Options Trading (NYSE:CAH)
Just Revealed: The chip company making AI look primitive
In his just-released video presentation, this renowned market strategist — who's been called "one of the most important money managers of our time" — reveals the company's name and ticker symbol at no cost. But he cautions: once mainstream investors recognize what's happening, the opportunity for maximum gains could evaporate overnight.
Elliott exits Cardinal Health, cuts NRG Energy in Q4
See More Cardinal Health Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Cardinal Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cardinal Health and other key companies, straight to your email.

About Cardinal Health

Cardinal Health (NYSE:CAH) operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

View Cardinal Health Profile

More Earnings Resources from MarketBeat